期刊文献+

大肠癌及癌旁黏膜组织中端粒酶活性检测的临床意义 被引量:1

Telomerase Activity in Colorectal Cancer and Adjacent Mucosa and its Clinical Significance
下载PDF
导出
摘要 目的 研究端粒酶活性检测在大肠癌临床诊断和确定手术切除范围中的意义。方法 应用已建立的银染TRAP方法 ,检测 2 9例大肠癌组织及癌旁 (近端即食管端距癌组织 2cm、4cm、6cm、10cm ,远端即肛门端距癌组织 2cm、4cm、6cm )黏膜组织 ,共 8个标本的端粒酶活性。结果 大肠癌组织的端粒酶活性阳性率为 89.7% ( 2 6/2 9) ,其中近端 2cm癌旁黏膜组织的阳性率为 13.8% ( 4/2 9) ,远端 2cm癌旁黏膜组织的阳性率为 3.4% ( 1/2 9)。而近端 4cm、6cm、10cm ,远端 4cm、6cm癌旁黏膜组织端粒酶活性检测阳性率均为 0 ( 0 /2 9)。端粒酶活性与大肠癌的分化程度及肠系膜淋巴结转移无相关性 (P >0 .0 5 )。结论 端粒酶活性既有可能成为大肠癌诊断的标志物 。 Objective To study the significance of the telomerase activity in the clinical diagnosis and surgery operation of human colorectal adenocarcinoma.Methods The telomerase activity in 29 cases of surgical resected colorectal cancer and the adjacent(2 cm,4 cm,6 cm,10 cm) mucosa tissues were examined with the silver staining TRAP method.Results The positive rate of telomerase activity of the colorectal adenocarcinoma tissues was 89.7%(26 out of 29).Telomerase activity was also detectable in 4(13.8%) of 29 colorectal adjacent(2 cm) mucosa tissues,whereas no enzyme activity was detected in the 29 adjacent (4 cm,6 cm,10 cm) mucosa tissues.There was no correlation between telomerase activity and clinical pathological features including histopathologic grading of the tumor and lymphatic transfer.Conclusion The results suggeste that telomerase activity determination may have potential diagnostic and prognostic value in the management of colorectal adenocarinoma.
出处 《实用癌症杂志》 2002年第2期167-169,共3页 The Practical Journal of Cancer
关键词 端粒酶 端粒重复序列扩增技术 大肠癌 癌旁黏膜 临床意义 Telomerase Telomere repeat amplification protocol(TRAP) Colorectal adenocarcinoma Adjacent mucosa
  • 相关文献

参考文献1

二级参考文献3

  • 1万小云.端粒,端粒酶与恶性肿瘤[J].国外医学:妇产科学分册,1997,24:202-202.
  • 2Engelhardt M,J Natl Cancer Inst,1997年,89卷,1609页
  • 3万小云,国外医学.妇产科分册,1997年,24卷,202页

共引文献4

同被引文献12

  • 1耿敬姝,宋鸿涛,王艳颖.复发直肠癌切端的细胞增殖动力学分析[J].中国肿瘤临床,2004,31(12):661-663. 被引量:3
  • 2吴云飞,陈峻青,何三光,马东初.胃癌细胞DNA含量、细胞增殖比率与淋巴结转移规律的研究[J].中华肿瘤杂志,1997,19(1):62-64. 被引量:19
  • 3Ishikuro A, Dosaka Akita H, Kato M, et al. ki-67Labeling Indics in non-small cell lung cancer:Comparation between ICM and FCM [J]. Cytomytry, 1997, 30: 186.
  • 4Aoki R, Tanaka S, Haruma K, et al. MUC-1 expression as a predictor of the curative endoscopic treatment of submucosally invasive colorectal carcinoma [J]. Dis Colon Rectum, 1998, 41:1 262.
  • 5Jen J, Kim H, Piantadosi S, et al. Allelic loss of chromosom 18q and prognosis in colorectal cancer [J]. N Engl J Med ,1994, 331:213.
  • 6Kim IJ, Shin Y, Kang HC, et al. Robust microsatellite instability(MSI) analysis by denaturing high-performance liquid chromatography (DHPLC) [J]. J Hum Genet, 2003, 48(10): 525.
  • 7Gohn S. P53 and behavior of colorectal cancer [J]. Lancet, 1994,344:233.
  • 8Campo E. Prognostic significance of loss of heterozygosity of Nm23-HI and P53 genes in human colorectal carcinomas [J]. Cancer,1994, 73:2913.
  • 9Broker T, Schlegel J, Kullmann F, et al. Genomic instability in colorectal carcinomas:comparison of different evaluation methods andtheir biogical significance [J]. J Pathol, 1996, 179:15.
  • 10Gervaz P, Bouzourene H, Cerottini JP, et al. Dukes B colorectal cancer: distinct genetic categories and clinical outcome based on proximal or distal tumor location [J]. Dis Colon Rectum, 2001, 44(3):364.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部